Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype

British Journal of Cancer

Volumn 102, Issue 12, 2010, Pages 1736-1745

  Kristiansen, G ^a   Rose, M ^b   Geisler, C ^b   Fritzsche, F R ^c   Gerhardt, J ^a   Luke C ^d   Ladhoff, A M ^d   Knuchel R ^b   Dietel, M ^d   Moch, H ^a   Varga, Z ^a   Theurillat, J P ^a   Gorr, T A ^c   Dahl, E ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Breast cancer; Fatty acids; Luminal type; Myoglobin; Oestrogen receptor

Indexed keywords

CARBONATE DEHYDRATASE IX; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FATTY ACID SYNTHASE; GLUCOSE TRANSPORTER 1; HORMONE RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MESSENGER RNA; MYOGLOBIN; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; BREAST CELL; CANCER CELL; CANCER INVASION; CELL SCREENING; CLINICAL ARTICLE; COHORT ANALYSIS; CORRELATION ANALYSIS; DATA MINING; FATTY ACID METABOLISM; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INCIDENCE; LIPID METABOLISM; MICRODISSECTION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; UPREGULATION;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL LINE, TUMOR; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MYOGLOBIN; NEOPLASM INVASIVENESS; NEOPLASMS, HORMONE-DEPENDENT; PHENOTYPE; PROGNOSIS; RNA, MESSENGER;

EID: 77953264467     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605702     Document Type: Article

References (52)

1. Arcasoy MO, Amin K, Karayal AF, Chou SC, Raleigh JA, Varia MA, Haroon ZA (2002) Functional significance of erythropoietin receptor expression in breast cancer. Lab Invest 82: 911-918
2. Bhargava R, Beriwal S, Dabbs DJ, Ozbek U, Soran A, Johnson RR, Brufsky AM, Lembersky BC, Ahrendt GM (2010) Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy: a single institutional experience with 359 cases. Cancer 116: 1431-1439
3. Brown JM (1999) The hypoxic cell: a target for selective cancer therapy-eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res 59: 5863-5870
4. Brown JM, Wilson WR (2004) Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 4: 437-447
5. Brunori M (2001) Nitric oxide moves myoglobin centre stage. Trends Biochem Sci 26: 209-210
6. Cheng G, Li Y, Omoto Y, Wang Y, Berg T, Nord M, Vihko P, Warner M, Piao YS, Gustafsson JA (2005) Differential regulation of estrogen receptor (ER)alpha and ERbeta in primate mammary gland. J Clin Endocrinol Metab 90: 435-444
7. Coser KR, Chesnes J, Hur J, Ray S, Isselbacher KJ, Shioda T (2003) Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray. Proc Natl Acad Sci USA 100: 13994-13999
8. Elston EW, Ellis IO (1993) Method for grading breast cancer. J Clin Pathol 46: 189-190
9. Eusebi V, Bondi A, Rosai J (1984) Immunohistochemical localization of myoglobin in nonmuscular cells. Am J Surg Pathol 8: 51-55
10. Farmer P, Bonnefoi H, Becette V, Tubiana-Hulin M, Fumoleau P, Larsimont D, Macgrogan G, Bergh J, Cameron D, Goldstein D, Duss S, Nicoulaz AL, Brisken C, Fiche M, Delorenzi M, Iggo R (2005) Identification of molecular apocrine breast tumours by microarray analysis. Oncogene 24: 4660-4671
11. Flögel U, Gödecke A, Klotz LO, Schrader J (2004) Role of myoglobin in the antioxidant defense of the heart. FASEB J 18: 1156-1158
12. Flögel U, Laussmann T, Gödecke A, Abanador N, Schafers M, Fingas CD, Metzger S, Levkau B, Jacoby C, Schrader J (2005) Lack of myoglobin causes a switch in cardiac substrate selection. Circ Res 96: e68-e75
13. Flögel U, Merx MW, Gödecke A, Decking UK, Schrader J (2001) Myoglobin: a scavenger of bioactive NO. Proc Natl Acad Sci USA 98: 735-740
14. Flonta SE, Arena S, Pisacane A, Michieli P, Bardelli A (2009) Expression and functional regulation of myoglobin in epithelial cancers. Am J Pathol 175: 201-206
15. Galluzzo M, Pennacchietti S, Rosano S, Comoglio PM, Michieli P (2009) Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis. J Clin Invest 119: 865-875
16. Garry DJ, Ordway GA, Lorenz JN, Radford NB, Chin ER, Grange RW, Bassel-Duby R, Williams RS (1998) Mice without myoglobin. Nature 395: 905-908
17. Gloster J, Harris P (1977) Fatty acid binding to cytoplasmic proteins of myocardium and red and white skeletal muscle in the rat. A possible new role for myoglobin. Biochem Biophys Res Commun 74: 506-513
18. Gödecke A, Flögel U, Zanger K, Ding Z, Hirchenhain J, Decking UK, Schrader J (1999) Disruption of myoglobin in mice induces multiple compensatory mechanisms. Proc Natl Acad Sci USA 96: 10495-10500
19. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC (1953) The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26: 638-648
20. Hendgen-Cotta UB, Merx MW, Shiva S, Schmitz J, Becher S, Klare JP, Steinhoff HJ, Goedecke A, Schrader J, Gladwin MT, Kelm M, Rassaf T (2008) Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury. Proc Natl Acad Sci USA 105: 10256-10261
21. Iseki M, Tsuda N, Kishikawa M, Shimada O, Hayashi T, Kawahara K, Tomita M (1990) Thymolipoma with striated myoid cells. Histological, immunohistochemical, and ultrastructural study. Am J Surg Pathol 14: 395-398
22. Jamieson S, Rudland PS (1990) Identification of metaplastic variants generated by transfection of a nonmetastatic rat mammary epithelial cell line with DNA from a metastatic rat mammary cell line. Am J Pathol 137: 629-641
23. Jürgens KD, Peters T, Gros G (1994) Diffusivity of myoglobin in intact skeletal muscle cells. Proc Natl Acad Sci USA 91: 3829-3833
24. Kendrew JC (1958) Architecture of a protein molecule. Nature 182: 764-767
25. Khan KK, Mondal MS, Padhy L, Mitra S (1998) The role of distal histidine in peroxidase activity of myoglobin-transient-kinetics study of the reaction of H2O2 with wild-type and distal-histidine-mutanted recombi-nant human myoglobin. Eur J Biochem 257: 547-555
26. Kristiansen G, Fritzsche FR, Wassermann K, Jager C, Tolls A, Lein M, Stephan C, Jung K, Pilarsky C, Dietel M, Moch H (2008) GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Br J Cancer 99: 939-948
27. Kuhajda FP, Pizer ES, Li JN, Mani NS, Frehywot GL, Townsend CA (2000) Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc Natl Acad Sci USA 97: 3450-3454
28. Kurebayashi J (2003) Endocrine-resistant breast cancer: underlying mechanisms and strategies for overcoming resistance. Breast Cancer 10: 112-119
29. Lewis UJ, Cheever EV, Seavey BK (1968) Influence of fatty acids on the electrophoretic behavior of proteins with special reference to pituitary hormone and thyroglobulin. J Biol Chem 243: 260-267
30. Mashima T, Seimiya H, Tsuruo T (2009) De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer 100: 1369-1372
31. Massaad-Massade L (2004) [Hypoxia, HIF1alpha and estrogen receptor]. Bull Cancer 91: 677-683
32. Masuda K, Truscott K, Lin PC, Kreutzer U, Chung Y, Sriram R, Jue T (2008) Determination of myoglobin concentration in blood-perfused tissue. Eur J Appl Physiol 104: 41-48
33. Menendez JA, Lupu R (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7: 763-777
34. Nitta T, Xundi X, Hatano E, Yamamoto N, Uehara T, Yoshida M, Harada N, Honda K, Tanaka A, Sosnowski D, Chance B, Yamaoka Y (2003) Myoglobin gene expression attenuates hepatic ischemia reperfusion injury. J Surg Res 110: 322-331
35. Ordway GA, Garry DJ (2004) Myoglobin: an essential hemoprotein in striated muscle. J Exp Biol 207: 3441-3446
36. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406: 747-752
37. Ruck P, Horny HP, Greschniok A, Wehrmann M, Kaiserling E (1995) Nonspecific immunostaining of blast cells of acute leukemia by antibodies against nonhemopoietic antigens. Hematol Pathol 9: 49-56
38. Smith TW, Davidson RI (1984) Medullomyoblastoma. A histologic, immunohistochemical, and ultrastructural study. Cancer 54: 323-332
39. Sobin LH, Wittekind Ch (eds) (2002) TNM Classification of Malignant Tumours. Wiley-Liss, Inc.: New York
40. Sriram R, Kreutzer U, Shih L, Jue T (2008) Interaction of fatty acid with myoglobin. FEBS Lett 582: 3643-3649
41. Tavassoli FA, Devilee P (eds) (2003) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC Press: Lyon
42. Theurillat JP, Ingold F, Frei C, Zippelius A, Varga Z, Seifert B, Chen YT, Jager D, Knuth A, Moch H (2007) NY-ESO-1 protein expression in primary breast carcinoma and metastases: correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltration. Int J Cancer 120: 2411-2417
43. Thews O, Koenig R, Kelleher DK, Kutzner J, Vaupel P (1998) Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia. Br J Cancer 78: 752-756
44. Thomlinson RH, Gray LH (1955) The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 9: 539-549
45. Vaupel P, Schlenger K, Knoop C, Hockel M (1991) Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res 51: 3316-3322
46. Vaupel P, Schlenger KH, Hoeckel M, Okunieff P (1992) Oxygenation of mammary tumors: from isotransplanted rodent tumors to primary malignancies in patients. Adv Exp Med Biol 316: 361-371
47. Veeck J, Niederacher D, An H, Klopocki E, Wiesmann F, Betz B, Galm O, Camara O, Durst M, Kristiansen G, Huszka C, Knuchel R, Dahl E (2006) Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis. Oncogene 25: 3479-3488
48. Wittenberg BA, Wittenberg JB, Caldwell PR (1975) Role of myoglobin in the oxygen supply to red skeletal muscle. J Biol Chem 250: 9038-9043
49. Wittenberg JB (1970) Myoglobin-facilitated oxygen diffusion: role of myoglobin in oxygen entry into muscle. Physiol Rev 50: 559-636
50. Yackzan KS, Wingo WJ (1982) Transport of fatty acids by myoglobin-a hypothesis. Med Hypotheses 8: 613-618
51. Yang GC, Yee HT, Waisman J (2003) Metaplastic carcinoma of the breast with rhabdomyosarcomatous element: aspiration cytology with histo-logical, immunohistochemical, and ultrastructural correlations. Diagn Cytopathol 28: 153-158
52. Zhang PJ, Goldblum JR, Pawel BR, Fisher C, Pasha TL, Barr FG (2003) Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product. Mod Pathol 16: 229-235